Business1 sourcesNeutral

Sagimet Biosciences Announces Poster And Oral Presentations At The Fueling MASH: Metabolic Drivers And Inflammatory Crosstalk Keystone Symposium And Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

(MENAFN - GlobeNewsWire - Nasdaq) SAN MATEO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel ...

Menafn

via Menafn

April 6, 2026 | 7:01 AM UTCUpdated 2h ago

Share Read original

Read the full article at Menafn →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Menafn

NewsData

Comments

0 comments

Be respectful and constructive.

Loading comments...

South Korea says 'credible intelligence' indicates North Korean leader's daughter is successor

Business

Mass. cannabis reforms approved by legislative committee

Bryan Hecht-57m ago-1 sources

Business

Drone Incursions Over U.S. Bases Raise Security Concerns As Iran Tensions Escalate

Merin Rebecca Thomas-1h ago-1 sources

Business

Why FuboTV Stock Popped Today

Joe Tenebruso-1h ago-1 sources

Sagimet Biosciences Announces Poster And Oral Presentations At The Fueling MASH: Metabolic Drivers And Inflammatory Crosstalk Keystone Symposium And Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Source Verification

Comments

South Korea says 'credible intelligence' indicates North Korean leader's daughter is successor

Samsung Galaxy Glasses (2026): Specs, Price, and Android XR

Related Articles

Mass. cannabis reforms approved by legislative committee

Drone Incursions Over U.S. Bases Raise Security Concerns As Iran Tensions Escalate

Why FuboTV Stock Popped Today